A critical evaluation of vestibular schwannoma surgery for patients younger than 40 years of age

Neurosurgery

Volumn 67, Issue 6, 2010, Pages 1646-1653

  Sughrue, Michael E ^a   Kaur, Rajwant ^a   Rutkowski, Martin J ^a   Kane, Ari J ^a   Yang, Isaac ^a   Pitts, Lawrence H ^a   Parsa, Andrew T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acoustic neuroma; Long term; Microsurgery; Outcome; Vestibular schwannoma; Young

Indexed keywords

ACOUSTIC NEURINOMA; ADULT; ARTICLE; CANCER CONTROL; CLINICAL ASSESSMENT; FACIAL NERVE PARALYSIS; FEMALE; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIOSURGERY; RISK FACTOR; TRIGEMINUS NEURALGIA; TUMOR VOLUME;

ADULT; CHI-SQUARE DISTRIBUTION; FACIAL NERVE DISEASES; FEMALE; HEARING LOSS; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; NEUROMA, ACOUSTIC; POSTOPERATIVE COMPLICATIONS; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78650513003     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3181f8d3d3     Document Type: Article

References (25)

1. Yang I, Sughrue ME, Han SJ, et al. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg. 2010;112(4):851-859.
2. Sughrue ME, Yang I, Aranda D, et al. The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. J Neurosurg. 2010;112(1):163-167.
3. Yang I, Sughrue ME, Han SJ, et al. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol. 2009;93(1):41-48.
4. Yang I, Aranda D, Han SJ, et al. Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci. 2009;16(6):742-747.
5. Sughrue ME, Yang I, Aranda D, et al. The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. J Neurosurg. 2010;112(1):163-167.
6. Sughrue ME, Yang I, Aranda D, et al. Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg. 2009 Nov 27. [Epub ahead of print].
7. Sughrue ME, Yang I, Han SJ, et al. Non-audiofacial morbidity after Gamma Knife surgery for vestibular schwannoma. Neurosurg Focus. 2009;27(6):E4.
8. Sughrue ME, Yeung AH, Rutkowski MJ, Cheung SW, Parsa AT. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics. J Neurosurg. 2009 Nov 27. [Epub ahead of print].
9. Yeung AH, Sughrue ME, Kane AJ, Tihan T, Cheung SW, Parsa AT. Radiobiology of vestibular schwannomas: mechanisms of radioresistance and potential targets for therapeutic sensitization. Neurosurg Focus. 2009;27(6):E2.
10. Kondziolka D, Lunsford LD, Flickinger JC. Gamma knife radiosurgery for vestibular schwannomas. Neurosurg Clin N Am. 2000;11(4):651-658.
11. Samii M, Gerganov V, Samii A. Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg. 2006;105(4):527-535.
12. Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): hearing function in 1000 tumor resections. Neurosurgery. 1997;40(2):248-260; discussion 260-262.
13. Samii M, Matthies C, Tatagiba M. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery. 1997;40(4):696-705; discussion 705-706.
14. Samii M, Tatagiba M, Matthies C. Acoustic neurinoma in the elderly: factors predictive of postoperative outcome. Neurosurgery. 1992;31(4):615-619; discussion 619-620.
15. Barker FG 2nd, Carter BS, Ojemann RG, Jyung RW, Poe DS, McKenna MJ. Surgical excision of acoustic neuroma: patient outcome and provider caseload. Laryngoscope. 2003;113(8):1332-1343.
16. Lobato-Polo J, Kondziolka D, Zorro O, Kano H, Flickinger JC, Lunsford LD. Gamma Knife radiosurgery in younger patients with vestibular schwannomas. Neurosurgery. 2009;65(2):294-300; discussion 300-301.
17. Rowe J, Grainger A, Walton L, Silcocks P, Radatz M, Kemeny A. Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery. 2007;60(1):60- 65; discussion 65-66.
18. Muracciole X, Cowen D, Regis J. [Radiosurgery and brain radio-induced carcinogenesis: update]. Neurochirurgie. 2004;50(2-3 Pt 2):414-420.
19. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg, 1995, 113 n. 3, 179-180.
20. Hosmer DW, Lemeshow S.Applied Logistic Regression. 2nd ed. New York: John Wiley; 2000.
21. Hosmer DW, Hjort NL. Goodness-of-fit processes for logistic regression: simulation results. Stat Med. 2002;21(18):2723-2738.
22. Aghi M, Kluwe L, Webster MT, et al. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype. J Neurosurg. 2006;104(2):201-207.
23. Rastogi P, Cacace AT, Lovely TJ. Factors influencing hearing preservation in acoustic tumor surgery. Skull Base Surg. 1995;5(3):137-142.
24. Brackmann DE, Owens RM, Friedman RA, et al. Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol. 2000;21(3): 417-424.
25. Yates PD, Jackler RK, Satar B, Pitts LH, Oghalai JS. Is it worthwhile to attempt hearing preservation in larger acoustic neuromas Otol Neurotol. 2003;24(3):460-464.